Comparison of Atezolizumab/Bevacizumab Versus Durvalumab/Tremelimumab (STRIDE) Protocols in Locally Advanced or Metastatic Hepatocellular Carcinoma Among Patients in Sohag

Name: Comparison of Atezolizumab/Bevacizumab Versus Durvalumab/Tremelimumab (STRIDE) Protocols in Locally Advanced or Metastatic Hepatocellular Carcinoma Among Patients in Sohag
License: Public Domain

Sohag Oncology Center

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

locally advanced or metastatic hepatoceullar carcinoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 424177
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.